Member Contact: Clint Rodgers
Position: Vice President Marketing and Communications (Global)
Industry: Medtech & Digital
Through application of its unique XV Technology™, 4DMedical is providing clinicians and researchers with greater insights into lung function and the impact of diseases and treatment interventions. Patients are informed and empowered through such knowledge. Researchers and industry partners utilise our technology to understand the efficacy of therapeutic interventions.
This unique capability accurately and quickly scans lung function as the patient breathes, assisting in providing sensitive and early diagnoses, and in monitoring changes over time. Software-as-a-Service (SaaS)-enabled scans deliver comprehensive information and insights, showing even subtle variations in lung function down to the finest details, without the need for contrast agents.
Better information means better decisions, and better outcomes.
Based in Melbourne and Los Angeles, 4DMedical was founded in 2012 by Dr Andreas Fouras and is listed on the Australian Securities Exchange (ASX: 4DX).